- Home
- TSQ vs ATOS Comparison
TSQ vs ATOS Comparison
Compare TSQ & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSQ
- ATOS
- Stock Information
- Founded
- TSQ 1996
- ATOS 2009
- Country
- TSQ United States
- ATOS United States
- Employees
- TSQ N/A
- ATOS N/A
- Industry
- TSQ Broadcasting
- ATOS Biotechnology: Pharmaceutical Preparations
- Sector
- TSQ Consumer Discretionary
- ATOS Health Care
- Exchange
- TSQ Nasdaq
- ATOS Nasdaq
- Market Cap
- TSQ 155.1M
- ATOS 174.8M
- IPO Year
- TSQ 2000
- ATOS 2012
- Fundamental
- Price
- TSQ $9.95
- ATOS $1.19
- Analyst Decision
- TSQ Strong Buy
- ATOS Strong Buy
- Analyst Count
- TSQ 3
- ATOS 3
- Target Price
- TSQ $16.83
- ATOS $6.75
- AVG Volume (30 Days)
- TSQ 41.4K
- ATOS 738.2K
- Earning Date
- TSQ 11-07-2024
- ATOS 11-12-2024
- Dividend Yield
- TSQ 7.93%
- ATOS N/A
- EPS Growth
- TSQ N/A
- ATOS N/A
- EPS
- TSQ N/A
- ATOS N/A
- Revenue
- TSQ $447,955,000.00
- ATOS N/A
- Revenue This Year
- TSQ $1.02
- ATOS N/A
- Revenue Next Year
- TSQ $0.72
- ATOS N/A
- P/E Ratio
- TSQ N/A
- ATOS N/A
- Revenue Growth
- TSQ N/A
- ATOS N/A
- 52 Week Low
- TSQ $9.36
- ATOS $0.70
- 52 Week High
- TSQ $13.57
- ATOS $2.31
- Technical
- Relative Strength Index (RSI)
- TSQ 48.05
- ATOS 31.91
- Support Level
- TSQ $9.61
- ATOS $1.26
- Resistance Level
- TSQ $10.29
- ATOS $1.66
- Average True Range (ATR)
- TSQ 0.34
- ATOS 0.09
- MACD
- TSQ 0.00
- ATOS -0.03
- Stochastic Oscillator
- TSQ 34.67
- ATOS 4.08
About TSQ Townsquare Media Inc.
Townsquare Media Inc is a radio, digital media, entertainment, and digital marketing solutions company principally focused on being the premier local advertising and marketing solutions platform in small and mid-sized markets across the United States. It has three segments which are Subscription Digital Marketing Solutions, Digital Advertising, and Broadcast Advertising. It earns the majority of the revenue from the Broadcasting Advertising segment, which includes its local, regional, and national advertising products and solutions delivered via terrestrial radio broadcast. Its portfolio includes local media brands such as WYRK.com, WJON.com, and NJ101.5.com, and premier national music brands such as XXLmag.com, TasteofCountry.com, UltimateClassicRock.com, and Loudwire.com.
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.